Propeller Health platform will integrate with MIR spirometers

Propeller Health has announced that its inhaler monitoring platform will integrate with mobile and clinical spirometers from Medical International Research (MIR). According to Propeller, its platform “is the only commercially marketed respiratory digital health solution to include FDA cleared inhaler sensors, digital interfaces and truly mobile spirometers.”

Presspart and Cohero Health’s recently launched eMDI will also integrate with a mobile spirometer through Cohero’s Breathesmart app.

Propeller CEO David Van Sickle commented, “We’re excited to partner with MIR to introduce their connected spirometers to participants in Propeller. Periodic assessment can be helpful in monitoring whether treatment is truly controlling symptoms and improving quality of life. These next-generation, mobile spirometers make it possible for patients to better understand their lung function at home and in the community.”

MIR USA National Sales and Business Development Manager John Cello said, “I am excited about this partnership with Propeller as it offers our customers a new option in the digital management of respiratory diseases making available a comprehensive range of sensors. It happens at the right time now that MIR has launched a new generation of truly ‘smart’ spirometers, which provide the same accuracy of a clinical setting and connect wirelessly to the Propeller System.”

Read the Propeller Health press release.

Share

published on

Featured event:

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA

September 24-September 25Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK